Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Med.

Sec. Ophthalmology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1654643

This article is part of the Research TopicNew Concepts, Advances, and Future Trends in Clinical Research on Eye DiseasesView all 56 articles

Clinical Manifestations and Outcomes of HSK Following Corneal Transplantation

Provisionally accepted
Dan  WuDan Wu1Hui  HuangHui Huang1Min  ZhengMin Zheng1Qi  ChenQi Chen1Zhou  ZhouZhou Zhou1Li  JiangLi Jiang1Yuanhua  LiYuanhua Li1Yiyun  LiuYiyun Liu2Baikai  MaBaikai Ma2Guoqing  ChenGuoqing Chen1Yujun  HuangYujun Huang1Fengping  CenFengping Cen1Binghua  ChenBinghua Chen1Fengmei  LiFengmei Li1Hong  QiHong Qi1*Fan  XuFan Xu1*Qianqian  LanQianqian Lan1*
  • 1Department of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
  • 2Peking University Third Hospital Ophthalmology Department, Beijing, China

The final, formatted version of the article will be published soon.

Purpose: To investigate the clinical manifestations and outcomes of herpes simplex keratitis (HSK) infection following corneal transplantation. Methods: This retrospective study analyzed medical records of patients who underwent corneal transplantation at the People's Hospital of Guangxi Zhuang Autonomous Region between January 2018 and March 2024, with a minimum follow-up period of one year. The study examined post-transplantation HSV infections, including the timing of herpes simplex virus (HSV) infection, HSK classification, clinical manifestations, and outcomes.Results: A total of 411 patients (411 eyes) were followed up. Among them, 88 cases (21.41% of 411 cases) were diagnosed with or suspected of HSK before corneal transplantation. Of these 88 cases, 13 cases (14.77% of 88 cases) developed recurrent HSK after surgery (8 cases underwent corneal transplantation during the acute phase, and 5 cases during the scarring phase). There were 323 cases with no evidence of HSK before corneal transplantation, among which 27 cases (8.36% of 323 cases) developed new-onset HSK after corneal transplantation. Among all 411 patients, a total of 40 cases (9.73% of 411 cases) developed HSK after corneal transplantation. Regarding HSK types: epithelial HSK occurred in 11 cases (27.5% of 40 cases), all of which achieved corneal transparency. Stromal necrotizing HSK occurred in 8 cases (20% of 40 cases), with 2 cases developing corneal nebula, 5 cases developing corneal macula, and 1 case requiring repeat corneal transplantation due to near-perforation. Combined epithelial, stromal, and endothelial HSK occurred in 17 cases (42.5% of 40 cases), with 1 case developing corneal nebula, 4 cases developing corneal macula, 10 cases developing corneal leucoma, and 2 cases requiring repeat corneal transplantation due to corneal perforation. Endothelial HSK occurred in 4 cases (10% of 40 cases), with 2 cases achieving grade 0 corneal transparency and 2 cases achieving grade 2 corneal transparency.Regular follow-up is essential for all patients post-surgery. For those with a history of HSK, vigilance for HSK is critical, while timely diagnosis and differentiation of HSK are crucial for non-HSK patients.When administering systemic antiviral therapy, it is important to adjust the frequency and intensity of steroid treatments promptly to prevent irreversible graft opacity.

Keywords: Herpes simplex keratitis, Corneal Transplantation, New-onset HSK, Recurrent HSK, HSK Classification

Received: 26 Jun 2025; Accepted: 28 Jul 2025.

Copyright: © 2025 Wu, Huang, Zheng, Chen, Zhou, Jiang, Li, Liu, Ma, Chen, Huang, Cen, Chen, Li, Qi, Xu and Lan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Hong Qi, Department of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
Fan Xu, Department of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
Qianqian Lan, Department of Ophthalmology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.